Abstract:Background Cumulative evidence suggests that atrial interleukin-6 (IL-6) may play a significant role in the development of spontaneous postoperative atrial fibrillation (sPOAF) in coronary artery bypass grafting (CABG) patients. Our previous studies found that the IL-6 produced by the atrium is positively related to the development of sPOAF. However, the causal relationship between IL-6 and sPOAF is not established. Purpose This study aims to explore the potential causality between atrial IL-6 and spontaneous AF(sAF), alongside assessing the impact of IL-6 on the electrophysiological properties of atrial myocytes (AM). Methods To determine the causal link between IL-6 and sAF, mice were randomly divided into eight groups: seven receiving injections of varying doses of recombinant IL-6 protein groups (15ng/kg to180ng/kg) into the left atrial wall, and one control group (vehicle). Mice were monitored for sAF for 7 days using implanted telemetry device. At 48 hrs post-injection, the left atrial appendages of another set of mice were collected for analyzing levels of IL-6, Myeloperoxidase (MPO), Transforming Growth Factor-β1 (TGF-β1), and Tumor Necrosis Factor-α (TNF-α). To assess the effect of IL-6 on the electrophysiological characteristics of AM, AMs were isolated from the hearts of 12-week-old mice and divided into experimental and control groups for electrophysiological testing. The experimental group was perfused with extracellular solutions containing 100 ng/mL of IL-6 while the control group was perfused with standard extracellular solutions. The measurements focused on action potential (AP), transient outward potassium current (Ito), and inward rectifier potassium current (Ik1) after a 30-minute perfusion. Results As depicted in Fig. 1A, a dose-response relationship between IL-6 levels and sAF occurrence was observed, with incidence increasing from 0% at 15 ng/kg to 75% at 180 ng/kg (χ2= 16.691, P = 0.005). The injection of IL-6 also induced the production of MPO, TGF-β1, and TNF-α with a dose-dependent effects (Fig. 2). In comparison to control, the AP duration at 90% (APD90) and APD50 of repolarization of atrial myocytes were significantly shortened in IL-6 group (Fig. 1B). For voltages from -10mV to +70mV, atrial myocytes in the IL-6 group showed significantly lower Ito current density than those in the control (Fig. 1C). No significant alterations were observed in the impact of IL-6 on Ik1 current density in atrial myocytes (Fig.1D). Conclusion To the best of our knowledge, this is the first study that experimentally tested the causal relation between IL-6 and sAF. The injection of IL-6 could cause the onset of sAF and produce MPO, TGF-β1, and TNF-α with a significant dose-dependent effect. The effect of IL-6 on inducing sAF might be through its effect on reducing APD and Ito current density in mouse atrial myocytes. This suggests that inhibition of atrial IL-6 might be a potential novel sPOAF prevention strategy.

Interleukin-33/ST2 Axis Involvement in Atrial Remodeling and Arrhythmogenesis

Ang II Enhances Atrial Fibroblast Autophagy and Promotes Atrial Remodeling Through the AT1-ERK-mTOR Signaling Pathway

Interleukin-17A Contributes to the Development of Post-Operative Atrial Fibrillation by Regulating Inflammation and Fibrosis in Rats with Sterile Pericarditis

ST2 Silencing Aggravates Ventricular Remodeling and Chronic Heart Failure in Rats by Mediating the IL-33/ST2 Axis

IL33/ST2 Contributes to Airway Remodeling Via P-Jnk MAPK/STAT3 Signaling Pathway in OVA-induced Allergic Airway Inflammation in Mice

Selective Blockade of Interleukin-6 Trans-signaling

Cross-talk Between Macrophages and Atrial Myocytes in Atrial Fibrillation

IL-33 Promotes Airway Remodeling in Asthma Through ST2/ERK1/2/MSK1 Signal Pathway

Interleukin-6-Mediated-Ca2+ Handling Abnormalities Contributes to Atrial Fibrillation in Sterile Pericarditis Rats

A Link Between Inflammation and Atrial Electrogenesis

The role of interleukins in pathogenesis and prognosis of atrial fibrillation

Group 2 innate lymphoid cells contribute to IL-33-mediated alleviation of cardiac fibrosis

Signal Transducer and Activator of Transcription 3/MicroRNA-21 Feedback Loop Contributes to Atrial Fibrillation by Promoting Atrial Fibrosis in a Rat Sterile Pericarditis Model

TGF-β1 Signal Pathway in the Regulation of Inflammation in Patients with Atrial Fibrillation.

Interleukin-6 levels in atrium and onset of spontaneous atrial fibrillation: is there a causal relationship

IL37-promotes resolution of the RHD-induced atrial inflammatory status and atrial fibrillation

IL-33 Promotes the Progression of Nonrheumatic Aortic Valve Stenosis Via Inducing Differential Phenotypic Transition in Valvular Interstitial Cells.

IL-33 Suppresses the Progression of Atherosclerosis Via the ERK1/2-IRF1-VCAM-1 Pathway.

The role of IL-6, IL-10, TNF-α and PD-1 expression on CD4 T cells in atrial fibrillation

Integrative human atrial modelling unravels interactive protein kinase A and Ca2+/calmodulin-dependent protein kinase II signalling as key determinants of atrial arrhythmogenesis

Serum extracellular vesicles containing MIAT induces atrial fibrosis, inflammation and oxidative stress to promote atrial remodeling and atrial fibrillation via blockade of miR‐485‐5p‐mediated CXCL10 inhibition